These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24342784)

  • 1. [Utility of hCG dosage in the management of gestational trophoblastic diseases].
    Zohoun AG; Hounmenou K; Mechtani Sel I; Razine R; Dami A; Filali A; Rahali DM; Tellal S
    Ann Biol Clin (Paris); 2013; 71(6):639-43. PubMed ID: 24342784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the clinical laboratory detection of gestational trophoblastic disease.
    Seki K; Matsui H; Sekiya S
    Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
    de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
    Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcome of gestational trophoblastic disease in lower Egypt.
    Zakaria A; Hemida R; Elrefaie W; Refaie E
    Afr Health Sci; 2020 Mar; 20(1):73-82. PubMed ID: 33402895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gestational trophoblastic disease].
    Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
    Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S; Sasaki Y; Iino K
    J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
    Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Gestational Trophoblastic Disease of the Fallopian Tube: A Case Series Analysis and Literature Review.
    Lu J; Yue X; Xu C; Lu X
    J Reprod Med; 2017; 62(3-4):147-52. PubMed ID: 30230306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin.
    Qian XQ; Chen LL; Li BH; Cheng XD; Wan XY
    J Obstet Gynaecol Res; 2016 Jun; 42(6):694-700. PubMed ID: 26916449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R; Limpongsanurak S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
    Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
    J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.